Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $9.5800 (-6.99%) ($9.5800 - $9.5800) on Thu. Feb. 4, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.97% (three month average) | RSI | 64 | Latest Price | $9.5800(-6.99%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 1.7% a day on average for past five trading days. | Weekly Trend | BCRX advances 7.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(43%) IBB(38%) IWO(37%) IWC(36%) IWM(36%) | Factors Impacting BCRX price | BCRX will decline at least -3.485% in a week (0% probabilities). VIXM(-19%) UUP(-13%) VXX(-8%) IGOV(-4%) TBT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.485% (StdDev 6.97%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $10.17(-5.8%) | 10 Day Moving Average | $9.61(-0.31%) | 20 Day Moving Average | $9.04(5.97%) | To recent high | -19.5% | To recent low | 90.3% | Market Cap | $1.69b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |